Common Contracts
2 similar Right to Sublicense Agreement contracts by Xenetic Biosciences, Inc.
Indicates portions of this exhibit that have been omitted and filed separately with the Securities and Exchange Commission pursuant to a request for confidential treatment. EXECUTION VERSION RIGHT TO SUBLICENSE AGREEMENTRight to Sublicense Agreement • May 5th, 2020 • Delaware
This Right to Sublicense Agreement (“Agreement”) is made and entered into as of October 27, 2017 by and between Baxalta Incorporated, Baxalta US Inc., and Baxalta GmbH (collectively, with their Affiliates, “Baxalta”) and Xenetic Biosciences, Inc. (with its Affiliates, “Xenetic”) (with Baxalta and Xenetic being the “Parties” and each individually, a “Party”).
RIGHT TO SUBLICENSE AGREEMENTRight to Sublicense Agreement • March 30th, 2018 • Xenetic Biosciences, Inc. • Pharmaceutical preparations • Delaware
This Right to Sublicense Agreement (“Agreement”) is made and entered into as of October 27, 2017 by and between Baxalta Incorporated, Baxalta US Inc., and Baxalta GmbH (collectively, with their Affiliates, “Baxalta”) and Xenetic Biosciences, Inc. (with its Affiliates, “Xenetic”) (with Baxalta and Xenetic being the “Parties” and each individually, a “Party”).
